288 related articles for article (PubMed ID: 28643854)
1. Olfactory dysfunction in the APP/PS1 transgenic mouse model of Alzheimer's disease: Morphological evaluations from the nose to the brain.
Yao ZG; Hua F; Zhang HZ; Li YY; Qin YJ
Neuropathology; 2017 Dec; 37(6):485-494. PubMed ID: 28643854
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-β deposition and olfactory dysfunction in an Alzheimer's disease model.
Wu N; Rao X; Gao Y; Wang J; Xu F
J Alzheimers Dis; 2013; 37(4):699-712. PubMed ID: 23948910
[TBL] [Abstract][Full Text] [Related]
3. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
[TBL] [Abstract][Full Text] [Related]
4. Valproic acid ameliorates olfactory dysfunction in APP/PS1 transgenic mice of Alzheimer's disease: Ameliorations from the olfactory epithelium to the olfactory bulb.
Yao ZG; Jing HY; Wang DM; Lv BB; Li JM; Liu FF; Fan H; Sun XC; Qin YJ; Zhao MQ
Pharmacol Biochem Behav; 2016 May; 144():53-9. PubMed ID: 26948859
[TBL] [Abstract][Full Text] [Related]
5. Denervation of the olfactory bulb leads to decreased Aβ plaque load in a transgenic mouse model of Alzheimer' s disease.
Bibari O; Lee S; Dickson TC; Mitew S; Vickers JC; Chuah MI
Curr Alzheimer Res; 2013 Sep; 10(7):688-96. PubMed ID: 23905998
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
[TBL] [Abstract][Full Text] [Related]
7. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
8. Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline.
Macklin L; Griffith CM; Cai Y; Rose GM; Yan XX; Patrylo PR
Exp Gerontol; 2017 Feb; 88():9-18. PubMed ID: 28025127
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the APP/PS1 mouse model of Alzheimer's disease in senescence accelerated background.
Lok K; Zhao H; Shen H; Wang Z; Gao X; Zhao W; Yin M
Neurosci Lett; 2013 Dec; 557 Pt B():84-9. PubMed ID: 24176881
[TBL] [Abstract][Full Text] [Related]
10. Locus coeruleus degeneration exacerbates olfactory deficits in APP/PS1 transgenic mice.
Rey NL; Jardanhazi-Kurutz D; Terwel D; Kummer MP; Jourdan F; Didier A; Heneka MT
Neurobiol Aging; 2012 Feb; 33(2):426.e1-11. PubMed ID: 21109328
[TBL] [Abstract][Full Text] [Related]
11. Cholinergic degeneration is associated with increased plaque deposition and cognitive impairment in APPswe/PS1dE9 mice.
Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
Behav Brain Res; 2013 Mar; 240():146-52. PubMed ID: 23178660
[TBL] [Abstract][Full Text] [Related]
12. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
[TBL] [Abstract][Full Text] [Related]
13. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
Liu HL; Zhao G; Zhang H; Shi LD
Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
[TBL] [Abstract][Full Text] [Related]
14. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
[TBL] [Abstract][Full Text] [Related]
15. Interneurons and beta-amyloid in the olfactory bulb, anterior olfactory nucleus and olfactory tubercle in APPxPS1 transgenic mice model of Alzheimer's disease.
Saiz-Sanchez D; De La Rosa-Prieto C; Ubeda-Bañon I; Martinez-Marcos A
Anat Rec (Hoboken); 2013 Sep; 296(9):1413-23. PubMed ID: 23904197
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
[TBL] [Abstract][Full Text] [Related]
17. Allicin ameliorates cognitive impairment in APP/PS1 mice via Suppressing oxidative stress by Blocking JNK Signaling Pathways.
Zhang H; Wang P; Xue Y; Liu L; Li Z; Liu Y
Tissue Cell; 2018 Feb; 50():89-95. PubMed ID: 29429523
[TBL] [Abstract][Full Text] [Related]
18. GABA
Hu B; Geng C; Guo F; Liu Y; Zong YC; Hou XY
Neurobiol Aging; 2021 Dec; 108():47-57. PubMed ID: 34507271
[TBL] [Abstract][Full Text] [Related]
19. Age Moderates the Effects of Traumatic Brain Injury on Beta-Amyloid Plaque Load in APP/PS1 Mice.
Collins JM; King AE; Woodhouse A; Kirkcaldie MTK; Vickers JC
J Neurotrauma; 2019 Jun; 36(11):1876-1889. PubMed ID: 30623730
[TBL] [Abstract][Full Text] [Related]
20. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
Zhao G; Liu HL; Zhang H; Tong XJ
Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
